Cargando…

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors

BACKGROUND AND AIMS: Analysed using classical frequentist hypothesis testing with alpha set to 0.05, the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) did not find enough evidence to reject the hypothesis of no difference in neuropsychiatric adverse events (NPSAEs) attributa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beard, Emma, Jackson, Sarah E., Anthenelli, Robert M., Benowitz, Neal L., Aubin, Lisa St., McRae, Thomas, Lawrence, David, Russ, Cristina, Krishen, Alok, Evins, A. Eden, West, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612131/ https://www.ncbi.nlm.nih.gov/pubmed/33885203 http://dx.doi.org/10.1111/add.15440

Ejemplares similares

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
por: West, Robert, et al.
Publicado: (2018)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial
por: Ayers, Catherine R., et al.
Publicado: (2019)

Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial()
por: McKee, Sherry A., et al.
Publicado: (2023)

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022)

Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012)

Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
por: Kotz, Daniel, et al.
Publicado: (2014)

Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
por: Aubin, H-J, et al.
Publicado: (2008)

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial
por: Tulloch, Heather E., et al.
Publicado: (2016)

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
por: Ramon, Josep M, et al.
Publicado: (2014)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial
por: Hajek, Peter, et al.
Publicado: (2013)

Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial
por: Davis, James M., et al.
Publicado: (2023)

Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
por: Kotz, Daniel, et al.
Publicado: (2015)

A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
por: Benli, Ali Ramazan, et al.
Publicado: (2017)

Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm
por: Rose, Jed E, et al.
Publicado: (2017)

General Practitioners' views on the provision of nicotine replacement therapy and bupropion
por: McEwen, Andy, et al.
Publicado: (2001)

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
por: Baker, Christine L, et al.
Publicado: (2018)

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013)

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo
por: Gonzales, David, et al.
Publicado: (2010)

Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials
por: Patel, Ashish R., et al.
Publicado: (2023)

A case of hypomania during nicotine cessation treatment with bupropion
por: Giasson-Gariépy, Karine, et al.
Publicado: (2013)

Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice
por: Lee, Lauren J., et al.
Publicado: (2018)

Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial
por: King, Andrea, et al.
Publicado: (2022)

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
por: Zawertailo, Laurie, et al.
Publicado: (2018)

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
por: Thomas, Kyla H, et al.
Publicado: (2015)

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022)

Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014)

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
por: Gonzales, D, et al.
Publicado: (2014)

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)

A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
por: Narayan, A. Lakshmi, et al.
Publicado: (2015)

2532: Predictive metabolism studies of varenicline and implications of its metabolites in nicotine addiction
por: Thompson, Keeshaloy, et al.
Publicado: (2018)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study
por: Thomas, Kyla H., et al.
Publicado: (2020)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol
por: Schuster, Randi M., et al.
Publicado: (2023)

Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation
por: Ascher, John, et al.
Publicado: (2018)

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat
por: Garcia-Rivas, Vernon, et al.
Publicado: (2019)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services
por: McEwen, Andy, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_e68vmsqivhild5aapo2b5fedr2